 Imaging evaluation is necessary to adequately characterize a palpable breast mass. After thorough clinical breast examination, usually by the referring clinician or by a specialist breast clinician, the radiologist must be able to establish concordance between the clinically detected mass and the imaging features at that location [2]. The negative predictive value of mammography with ultrasound (US) in the context of a palpable mass ranges from 97.4% to 100% [7-10]. Nevertheless, negative imaging evaluation should not deter biopsy when a strongly suspicious finding is present on physical examination. OR aUniversity of Michigan, Ann Arbor, Michigan. bResearch Author, Duke University Medical Center, Durham, North Carolina. cPanel Chair, Alpert Medical School of Brown University, Providence, Rhode Island. dPanel Vice-Chair, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. eWashington University School of Medicine, Saint Louis, Missouri. fPenn State Health Hershey Medical Center, Hershey, Pennsylvania. gUniversity of Utah, Salt Lake City, Utah. hKaiser Permanente, Atlanta, Georgia. iMemorial Sloan Kettering Cancer Center, New York, New York. jUniversity of Washington, Seattle, Washington; American College of Obstetricians and Gynecologists. kSt. Bernards Healthcare, Jonesboro, Arkansas. lDuke Signature Care, Durham, North Carolina; American College of Physicians. mUMass Memorial Medical Center/UMass Chan Medical School, Worcester, Massachusetts. nProMedica Breast Care, Toledo, Ohio. oFox Chase Cancer Center, Philadelphia, Pennsylvania; American College of Surgeons. pHoag Family Cancer Institute, Newport Beach, California and University of Southern California, Los Angeles, California; Commission on Nuclear Medicine and Molecular Imaging. qSpecialty Chair, NYU Clinical Cancer Center, New York, New York.
Palpable Breast Masses.  Imaging evaluation is necessary to adequately characterize a palpable breast mass. After thorough clinical breast examination, usually by the referring clinician or by a specialist breast clinician, the radiologist must be able to establish concordance between the clinically detected mass and the imaging features at that location [2]. The negative predictive value of mammography with ultrasound (US) in the context of a palpable mass ranges from 97.4% to 100% [7-10]. Nevertheless, negative imaging evaluation should not deter biopsy when a strongly suspicious finding is present on physical examination. OR aUniversity of Michigan, Ann Arbor, Michigan. bResearch Author, Duke University Medical Center, Durham, North Carolina. cPanel Chair, Alpert Medical School of Brown University, Providence, Rhode Island. dPanel Vice-Chair, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. eWashington University School of Medicine, Saint Louis, Missouri. fPenn State Health Hershey Medical Center, Hershey, Pennsylvania. gUniversity of Utah, Salt Lake City, Utah. hKaiser Permanente, Atlanta, Georgia. iMemorial Sloan Kettering Cancer Center, New York, New York. jUniversity of Washington, Seattle, Washington; American College of Obstetricians and Gynecologists. kSt. Bernards Healthcare, Jonesboro, Arkansas. lDuke Signature Care, Durham, North Carolina; American College of Physicians. mUMass Memorial Medical Center/UMass Chan Medical School, Worcester, Massachusetts. nProMedica Breast Care, Toledo, Ohio. oFox Chase Cancer Center, Philadelphia, Pennsylvania; American College of Surgeons. pHoag Family Cancer Institute, Newport Beach, California and University of Southern California, Los Angeles, California; Commission on Nuclear Medicine and Molecular Imaging. qSpecialty Chair, NYU Clinical Cancer Center, New York, New York.